Clinical Trials
To find out more about AVEO’s ongoing clinical trials evaluating tivozanib, ficlatuzumab and AV-203, please visit www.clinicaltrials.gov, or contact AVEO’s medical affairs department at medicalaffairs@aveooncology.com, or by phone at 617-299-5800 (option 1).
For additional resources online, please visit:
Kidney Cancer Association
American Cancer Society
CancerCare
National Cancer Institute

